BioDelivery Sciences
Raleigh
About BioDelivery Sciences
BioDelivery Sciences is a pharmaceutical company that focuses on pain management and addiction medicine. They are utilizing their novel and proprietary BioErodible MucoAdhesive (BEMA) drug delivery technology to develop and commercialize, either on their own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $50K – $100K
- Total funding: $250.7M
- Funding stage: M&A
- Last round: Post-IPO Debt (May 2019)
- Ticker: nasdaq:BDSI
- Website: bdsi.com
- Phone: (919) 582-9050
Industries & Categories
Biotechnology, Health Care, Life Science, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/biodelivery-sciences-162367 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.